The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
DataWarrior: An Open-Source Program For Chemistry Aware Data Visualization And Analysis
Abstract
Drug discovery projects in the pharmaceutical industry accumulate thousands of chemical structures and ten-thousands of data points from a dozen or more biological and pharmacological assays. A sufficient interpretation of the data requires understanding, which molecular families are present, which structural motifs correlate with measured properties, and which tiny structural changes cause large property changes. Data visualization and analysis software with sufficient chemical intelligence to support chemists in this task is rare. In an attempt to contribute to filling the gap, we released our in-house developed chemistry aware data analysis program DataWarrior for free public use. This paper gives an overview of DataWarrior's functionality and architecture. Exemplarily, a new unsupervised, 2-dimensional scaling algorithm is presented, which employs vector-based or nonvector-based descriptors to visualize the chemical or pharmacophore space of even large data sets. DataWarrior uses this method to interactively explore chemical space, activity landscapes, and activity cliffs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The WEKA data mining software: an update
Hall, M., Frank, E., Holmes, G., Pfahringer, B., Reutemann, P., & Witten, I. H. (2009) · ACM SIGKDD Explorations Newsletter · doi:10.1145/1656274.1656278 · Cited by 17,750
ChEMBL: a large-scale bioactivity database for drug discovery
Gaulton, A., Bellis, L. J., Bento, A. P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr777 · Cited by 4,382
Research works printed but not linked: 24
- Hey T., 2009, The Forth Paradigm: Data-Intensive Scientific Discovery
- Nielson G. M., 1997, Scientific Visualization: Overviews, Methodologies, and Techniques
- Chen W. L., 2006, J. Chem. Inf. Model., 46, 2230, 10.1021/ci060016u · DOI
- Ott M. A., 1992, Recl. Trav. Chim. Pays–Bas, 111, 239, 10.1002/recl.19921110601 · DOI
- Todd M. H., 2005, Chem. Soc. Rev., 34, 247, 10.1039/b104620a · DOI · Paper page
- 1996, TIBCO Spotfire
- 2012, Vortex
- ChemFinder Ultra;CambridgeSoft:Cambridge, MA, USA, 1998.
- Sander T., 2009, J. Chem. Inf. Model., 49, 232, 10.1021/ci800305f · DOI · Paper page
- Korff M. v., 2008, J. Chem. Inf. Model., 48, 797, 10.1021/ci700359j · DOI
- 2013, pKa-Predictor Plugin
- Lowe D. M., 2011, J. Chem. Inf. Model., 51, 739, 10.1021/ci100384d · DOI · Paper page
- Weininger D., 1988, J. Chem. Inf. Comput. Sci., 28, 31, 10.1021/ci00057a005 · DOI · Paper page
- von Korff M., 2006, J. Chem. Inf. Model., 46, 536, 10.1021/ci050358k · DOI
- Guha R., 2008, J. Chem. Inf. Model., 48, 646, 10.1021/ci7004093 · DOI · Paper page
- Morgan H. L., 1965, J. Chem. Doc., 5, 107, 10.1021/c160017a018 · DOI · Paper page
- Wipke W. T., 1974, J. Am. Chem. Soc., 96, 4834, 10.1021/ja00822a021 · doi:10.1021/ja00822a021
- Durant J. L., 2002, J. Chem. Inf. Model., 42, 1273
- James, C. A.; Weininger, D.,Daylight Theory Manual 4.34;Daylight CIS, Inc., March 1994; Version 1, Chapter 5: Fingerprints–Screening and Similarity, pp32–39.
- Bremser W., 1978, Anal. Chim. Acta, 103, 355, 10.1016/S0003-2670(01)83100-7 · DOI · Paper page
- Glem R. C., 2006, IDrugs: the investigational drugs journal, 9, 199
- Rogers D. J., 1960, Science., 132, 1115, 10.1126/science.132.3434.1115 · DOI · Paper page
- Kohonen T., 2001, Self-Organizing Maps, 10.1007/978-3-642-56927-2 · DOI · Paper page
- Borg I., 2005, Modern Multidimensional Scaling: theory and applications
Cited by
ZINC 15 – Ligand Discovery for Everyone
Sterling, T., & Irwin, J. J. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00559 · Cited by 3,224
Blunt, J. W., Carroll, A. R., Copp, B. R., Davis, R. A., Keyzers, R. A., & Prinsep, M. R. (2018) · Natural Product Reports · doi:10.1039/c7np00052a · Cited by 771
The LOTUS initiative for open knowledge management in natural products research
Rutz, A., Sorokina, M., Galgonek, J., Mietchen, D., Willighagen, E., Gaudry, A., Graham, J. G., Stephan, R., Page, R., Vondrášek, J., et al. (2022) · eLife · doi:10.7554/elife.70780 · Cited by 429
Computational Modeling of β-Secretase 1 (BACE-1) Inhibitors Using Ligand Based Approaches
Subramanian, G., Ramsundar, B., Pande, V., & Denny, R. A. (2016) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00290 · Cited by 285
Lagorce, D., Douguet, D., Miteva, M. A., & Villoutreix, B. O. (2017) · Scientific Reports · doi:10.1038/srep46277 · Cited by 266
Generative molecular design in low data regimes
Moret, M., Friedrich, L., Grisoni, F., Merk, D., & Schneider, G. (2020) · Nature Machine Intelligence · doi:10.1038/s42256-020-0160-y · Cited by 219
The many roles of molecular complexity in drug discovery
Méndez-Lucio, O., & Medina-Franco, J. L. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2016.08.009 · Cited by 180
Hybrid Search: A Method for Identifying Metabolites Absent from Tandem Mass Spectrometry Libraries
Cooper, B. T., Yan, X., Simón-Manso, Y., Tchekhovskoi, D. V., Mirokhin, Y. A., & Stein, S. E. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b03415 · Cited by 69
Li, W., Hu, Y., & Bischel, H. N. (2021) · Toxics · doi:10.3390/toxics9030063 · Cited by 53
“1 [45] to generate 3D structures for all ligands.”
BackgroundQiu, Y., Hou, Y., Gohel, D., Zhou, Y., Xu, J., Bykova, M., Yang, Y., Leverenz, J. B., Pieper, A. A., Nussinov, R., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114128 · Cited by 40
Lipophilic modification of salirasib modulates the antiproliferative and antimigratory activity
Ballari, M. S., O. J. Porta, E., Zalazar, E. A., Etichetti, C. M. B., Padrón, J. M., Girardini, J. E., & Labadie, G. R. (2023) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2023.117417 · Cited by 2
Metadata
- Authors
- Sander, T., Freyss, J., von Korff, M., & Rufener, C.
- Venue
- Journal of Chemical Information and Modeling
- Publisher
- American Chemical Society (ACS)
- Published
- 2015-02-02
- Volume
- 55
- Issue
- 2
- Pages
- 460-473
- ISSN
- 1549-9596 (ISSN-L)
- 1549-960X
- OpenAlex
- W1971849220
- Cited by
- 1,800
- References
- 2
- FWCI
- 56.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
